| Company Name: |
Carl Roth offre
|
| Tel: |
03.88.94.82.42 |
| Email: |
r.eckert@rothsochiel.fr |
| Products Intro: |
CAS:1183-35-3
|
|
| | DIHYDROOUABAIN Basic information |
| | DIHYDROOUABAIN Chemical Properties |
| Melting point | 168-170 °C | | Boiling point | 827.7±65.0 °C(Predicted) | | density | 1.49±0.1 g/cm3(Predicted) | | pka | 13.04±0.70(Predicted) |
| Hazard Codes | T | | Risk Statements | 23/24/25 | | Safety Statements | 36/37/39-45 | | RIDADR | 1544 | | WGK Germany | 3 | | RTECS | FH4551000 | | HazardClass | 6.1(b) | | PackingGroup | III | | Toxicity | LD50 intravenous in cat: 370mg/kg |
| | DIHYDROOUABAIN Usage And Synthesis |
| Uses | Dihydroouabain is a cardiac glycoside, a natural product found to be effective against various cancer cells. An inotropic drug and an inhibitor of sodium-potassium pump. | | Definition | ChEBI: Dihydroouabain is a cardenolide glycoside that is ouabain in which the double bond in the lactone ring has been reduced to a single bond. It is a cardiac glycoside and a derivative of ouabain which is used as a sodium pump antagonist and exhibits ionotropic effects. It has a role as a radiosensitizing agent and an EC 3.6.3.9 (Na(+)/K(+)-transporting ATPase) inhibitor. It is functionally related to an ouabain. |
| | DIHYDROOUABAIN Preparation Products And Raw materials |
|